ID   BT99
AC   CVCL_E6H7
SY   CPDM_1574X
RX   PubMed=24440720;
WW   Provider; CPDM; CPDM_1574X; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Brain, parietal lobe; UBERON=UBERON_0001872.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   59Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
RX   PubMed=24440720; DOI=10.1016/j.celrep.2013.12.032; PMCID=PMC4041390;
RA   Chudnovsky Y., Kim D., Zheng S.-Y., Whyte W.A., Bansal M., Bray M.-A.,
RA   Gopal S., Theisen M.A., Bilodeau S., Thiru P., Muffat J., Yilmaz O.H.,
RA   Mitalipova M., Woolard K.D., Lee J., Nishimura R., Sakata N., Fine H.A.,
RA   Carpenter A.E., Silver S.J., Verhaak R.G.W., Califano A., Young R.A.,
RA   Ligon K.L., Mellinghoff I.K., Root D.E., Sabatini D.M., Hahn W.C.,
RA   Chheda M.G.;
RT   "ZFHX4 interacts with the NuRD core member CHD4 and regulates the
RT   glioblastoma tumor-initiating cell state.";
RL   Cell Rep. 6:313-324(2014).
//